Tumor Necrosis Factor and Calpain 10 Polymorphism impacts in Women with GDM

Download PDF

Gestational Diabetes mellitus (GDM) results from an imbalance between insulin resistance and insulin secretion capacity during pregnancy. Tumor necrosis factor-alpha (TNF-α) is an inflammatory cytokine that is proposed to be involved in the pathogenesis of insulin resistance, and (CAPN10) has been detected as a susceptibility gene insulin resistance. The purpose of the present study was to recognize the impacts of the Tumor Necrosis Factor-alpha (-308 G/A) and CAPN10(-44 C/T, rs2975760) polymorphism on the development of GDM in the Saudi pregnant women population. We performed a case-control study and genotyped single nucleotide polymorphism of CAPN10(-44 C/T) gene and Tumor Necrosis Factor-alpha (-308 G/A) in 201 from the Western Saudi Arabia participants from Jeddah city including 101 patients with GDM and 100 normal (non-GDM). GDM and healthy subjects were genotyped with the PCR- RFLP technique. Heterozygocity for the gene polymorphisms did not occur more often in GDM women compared with non-GDM (TNF-alpha(-308 G/A): 41% versus 38%, p > 0.05; CAPN10(-44 C/T): 20% versus 17%; p > 0.05). Moreover, there was no outstanding difference between GDM and non GDM concerning homozygocity for (TNF alpha(-308 G/A)  5% versus 10%, p > 0.05); and CAPN10(-44 C/T) (2% versus 1%, p > 0.05). Contrary to the results of some other researchers, gene polymorphisms do not seem to be important in our population for the development of GDM. Tumor Necrosis Factor-alpha (-308 G/A) and CAPN10 (-44 C/T) genes are dependent on danger agents and might play roles in the risk of GDM.